View Older Stories View More Recent Stories
-
The Life Sciences Report Releases 2015 Small-Cap Biotech Watchlist Update
-
Ideal Power (IPWR) Prices 1.94M Common Offering at $7.75/Share
-
Ideal Power Inc. Prices Underwritten Public Offering of Common Stock
-
Ideal Power (IPWR) Announces Common Stock Offering
-
Ideal Power Inc. Announces Proposed Public Offering of Common Stock
-
Roth Capital Affirms Ligand Pharma (LGND) Following Positive SAGE-547 Update (SAGE)
-
Roth Capital Impressed by Trecora Resources (TREC) After Site Visit
-
Roth Capital Remain Bullish Leading up to Canadian Solar (CSIQ) Investor Day
-
Roth Capital 'Focus Pick' on TG Therapeutics (TGTX) Reiterated Amid ASCO Data
-
Argos Therapeutics (ARGS) Nearing Complete Enrollment in the Phase III ADAPT Study, Roth Capital Notes
-
Roth Capital Reiterated Bullish Stance on Aduro Biotech (ADRO) Following ASCO Abstracts
-
Roth Capital Raises Price Target Following Hackett Group's (HCKT) Q1 Results
-
Diamondback Energy (FANG) PT Raised at Roth Capital Despite EPS Miss
-
Roth Capital Reiterates Buy Following Clean Diesel Technologies (CDTI) Q1 Results
-
Roth Affirms Clean Diesel Tech (CDTI) at 'Buy'; HDD, Catalyst Performing Well
-
Roth Capital Remains Bullish Following Eco-stim Energy Solutions (ESES) Q1 Results
-
Roth Capital Remains Bullish Following Exar Corp. (EXAR) 4Q15 Results
-
Cytokinetics (CYTK) Clarifies Two Key Studies at R&D Event; Roth Affirms at 'Buy'
-
Roth Capital Says Consolidated Water Co (CWCO) Q1 Results Were 'Better than Meets the Eye'
-
NV5 Holdings (NVEE) Executing Well, Roth Capital Says; PT to $26
-
HII Technologies, Inc. Announces $3.05 Million Private Placement With Institutional and Accredited Investors
-
DepoMed (DEPO) Sell-Off an 'Over-Reaction', Roth Capital Says; PT to $28.50
-
Roth Capital Sidelined on Plug Power (PLUG) Until Path Towards Profitability Clears
-
New Products, Growing Distributor Base Remain Key for Revolution Lighting (RVLT) - Roth Capital
-
Nuverra Environmental (NES) is Stabilizing Business as E&P Activity Ebbs; Roth Boosts PT to $4
-
Roth Capital Lowers PT on LivePerson (LPSN) Following the Loss of AT&T
-
Roth Capital lowers PT Despite Manitex Int'l's (MNTX) Revenue Beat
-
Roth Capital Reiterates Buy For Applied Genetic Technologies (AGTC) Following Q3
-
Rexahn (RNN) Valuation Remains Compelling at Supinoxin, RX-3117 Phase 1 Milestones Near - Roth Capital
-
Roth Remains Positive on Daqo New Energy (DQ); Poly ASPs Can Remain at Current Levels for Only so Long
-
Streetinsider.com's Hot Lunchtime Reads 5/11: (LGND) (AAPL) (RL) (JPM) (OIL)
-
Ligand Pharma (LGND) PT Lifted to $127 at Roth Capital Following Q1 and as Pipeline Expands
-
Rexahn Pharmaceuticals Reports First Quarter 2015 Financial Results and Pipeline Update
-
Revolution Lighting Technologies Reports First Quarter 2015 Financial Results
-
SEC Compliance Featuring Products From Tauriga Sciences, Inc. at B. Riley & Co. Conference
-
Roth Capital Raises PT for Callon Petroleum (CPE) to $9.75 Following High Production in 1Q
-
Roth Capital Upgrades Hecla Mining (HL) to Buy
-
Roth Boosts PT on Concert Pharma (CNCE) to $22 Following; Deuterium Platform, Partnerships Will Bolster Gains
-
Winona Capital Invests In Diono® To Fuel Growth And Innovation
-
Roth Capital Reit Buy Following TearLab's (TEAR) 1Q Results
-
Roth Capital Assumes Power Solutions (PSIX) at Buy
-
SolarEdge Technologies (SEDG) Raises Guidance; Roth Capital Raises PT
-
Winona Capital Invests in Diono® to Fuel Growth and Innovation
-
Roth Capital Downgrades NVIDIA (NVDA) to Neutral
-
Roth Capital Partners Lowers PT on Planar Systems (PLNR) Anticipating 'Lull in Digital Signage'
-
Concerns Over Canadian Solar's (CSIQ) Q2 Outlook Likely 'Misplaced' - Roth Capital
-
Regeneron Pharma (REGN) PT Lifted to $490 at Roth Capital
-
ROTH Capital Partners Expands Technology with Addition of Brian Alger, CFA as a Senior Research Analyst In Technology
-
Roth Capital Upgrades SodaStream International (SODA) to Buy
-
Notable Analyst Rating Changes 5/6: (SRPT) (AXP) (YNDX) Upgraded; (NSM) (DEI) (FNFG) Downgraded

